AbbVie
Search results
Allergan is now part of AbbVie. We discover and develop innovative medicines for tomorrow, while helping people live better lives today.
In 1996, Allergan received FDA approval for Alphagan ophthalmic solution for open-angle glaucoma and ocular hypertension. In 1998, Allergan established The Allergan Foundation, a private US-based charitable foundation.
Allergan Aesthetics develops, manufactures, and markets a portfolio of leading brands and products including facial injectables, body contouring, plastics, skin care, and more. Skip to Main Content
May 8, 2020 · AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all...
Advantage is your online destination to access your favorite Allergan Aesthetics programs, product information, marketing materials, training resources and more. Sign up We create the products and technologies that drive the advancement of aesthetic medicine and empower confidence in practices, staff, and patients every day.
Allergan is now part of AbbVie. We discover and develop innovative medicines for tomorrow, while helping people live better lives today.
At Allergan ® Eye Care, our goal is to protect and preserve vision. It’s not just what we do—it’s who we are. We’ve been creating innovative products and services for our providers and our patients for over 75 years, and we continue to push the boundaries of what’s possible in eye care each and every day.
That day, AbbVie officially closed its $63-billion acquisition of Allergan to create a larger, stronger and more diversified global biopharmaceutical company. It was an acquisition that allowed us to grow in numbers and bolster our ability to improve people’s lives worldwide.
Allergan | 693,084 followers on LinkedIn. Allergan is now part of AbbVie. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the...
Allergan is now part of AbbVie. Together, we are dedicating more to R&D to drive tomorrow’s breakthroughs, while helping people live better lives today. With the Allergan acquisition, we are bringing together over 30 brands and leadership positions to expand and diversify our product portfolio.
